1
|
Cai P, Huang SN, Lin ZH, Wang Z, Liu RF, Xiao WH, Li ZS, Zhu ZH, Yao J, Yan XB, Wang FD, Zeng SX, Chen GQ, Yang LY, Sun YK, Yu C, Chen L, Wang WX. Regulation of wakefulness by astrocytes in the lateral hypothalamus. Neuropharmacology 2022; 221:109275. [PMID: 36195131 DOI: 10.1016/j.neuropharm.2022.109275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2021] [Revised: 09/03/2022] [Accepted: 09/26/2022] [Indexed: 10/07/2022]
Abstract
The lateral hypothalamus (LH) is an important brain region mediating sleep-wake behavior. Recent evidence has shown that central nervous system astrocytes modulate the activity of adjacent neurons and participate in several physiological functions. However, the role of LH astrocytes in sleep-wake regulation remains unclear. Here, using synchronous recording of electroencephalogram/electromyogram in mice and calcium signals in LH astrocytes, we show that the activity of LH astrocytes is significantly increased during non-rapid eye movement (NREM) sleep-to-wake transitions and decreased during wake-to-NREM sleep transitions. Chemogenetic activation of LH astrocytes potently promotes wakefulness and maintains long-term arousal, while chemogenetic inhibition of LH astrocytes decreases the total amount of wakefulness in mice. Moreover, by combining chemogenetics with fiber photometry, we show that activation of LH astrocytes significantly increases the calcium signals of adjacent neurons, especially among GABAergic neurons. Taken together, our results clearly illustrate that LH astrocytes are a key neural substrate regulating wakefulness and encode this behavior through surrounding GABAergic neurons. Our findings raise the possibility that overactivity of LH astrocytes may be an underlying mechanism of clinical sleep disorders.
Collapse
Affiliation(s)
- Ping Cai
- Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China
| | - Sheng-Nan Huang
- Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China
| | - Zhi-Hui Lin
- Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China
| | - Zewu Wang
- Public Technology Service Center, Fujian Medical University, Fuzhou, Fujian, China
| | - Ren-Fu Liu
- School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
| | - Wen-Hao Xiao
- School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
| | - Zhang-Shu Li
- School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
| | - Zhong-Hua Zhu
- School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
| | - Jing Yao
- Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China
| | - Xiong-Bin Yan
- School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
| | - Fu-Dan Wang
- Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China
| | - Shun-Xing Zeng
- School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
| | - Guo-Qiang Chen
- School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
| | - Liu-Yun Yang
- School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
| | - Yu-Kun Sun
- Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China
| | - Changxi Yu
- Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fujian Medical University, Fuzhou, Fujian, China.
| | - Li Chen
- Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fujian Medical University, Fuzhou, Fujian, China.
| | - Wen-Xiang Wang
- Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.
| |
Collapse
|